Showing 1 - 20 results of 173,572 for search '(( 50 n decrease ) OR ((( 5 wt decrease ) OR ( 10 ((teer decrease) OR (_ decrease)) ))))', query time: 0.92s Refine Results
  1. 1
  2. 2
  3. 3
  4. 4

    Scenario (6): Parameter variation (50% decrease)—With 5 N.m load applied at t = 0.3s. by Djaloul Karboua (16510091)

    Published 2023
    “…<p>Scenario (6): Parameter variation (50% decrease)—With 5 N.m load applied at t = 0.3s.…”
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10

    The GluN2B-C456Y mutation decreases recombinant NMDAR currents and alters receptor properties. by Wangyong Shin (6793040)

    Published 2020
    “…<i>n</i> = 4 oocytes for WT (pH IC<sub>50</sub> = 7.49 ± 0.016) and 5 oocytes for C456Y (pH IC<sub>50</sub> = 7.11 ± 0.0075), *<i>P</i> = 0.016, Mann-Whitney. …”
  11. 11
  12. 12

    NatB inactivation decreased the level of MAPK and proposed model of EGFR/MAPK signaling regulation by NatB and the N-end rule pathways. by Zhentao Sheng (107495)

    Published 2020
    “…<p>(A-B) <i>psid-D1</i> (A) or <i>psid-D4</i> (B) clones in 3rd instar fat body, which were marked by GFP expression (pointed by arrowheads), showed decreased MAPK levels (anti-MAPK staining, red). (C) <i>psid-D4</i> clones in wing disc, marked by GFP expression (pointed by arrowheads), showed decreased MAPK level. …”
  13. 13
  14. 14
  15. 15
  16. 16

    Spatial training decreases the association between Ndfip1 and Nedd4 and decreases endogenous Beclin 1 ubiquitination in the hippocampus. by Wei-Lun Hsu (1756123)

    Published 2023
    “…The Ndfip1 expression level is decreased in both the IP product and the lysate in trained rats. …”
  17. 17
  18. 18

    WT1 siRNA decreases proliferation, pAKT, and Bcl2 expression. by Ayana E. Morales (17756335)

    Published 2024
    “…<b>C.</b> RT-qPCR of WT1, p<0.05(*), vFLIP(ns), LANA, p<0.0001(****), K8.1, p<0.0001(****), and BCL2 p<0.05(*) in the setting of WT1 knockdown in ISLK BAC-16 with WT1 siRNA in comparison to a control siRNA using two-sided, unpaired student’s t-tests. …”
  19. 19

    GSK343 decreased tumor stemness. by Laura V. Bownes (10276762)

    Published 2021
    “…Treatment with GSK343 significantly decreased tumorsphere formation by both the COA3 (A) and COA6 (B) cells, representing a decrease in stem cell-like phenotype. …”
  20. 20